Imunon (IMNN) Operating Leases (2019 - 2026)
Imunon's (IMNN) quarterly Operating Leases came in at $492849.0 in Q1 2026, down 19.62% YoY from $613171.0 in Q1 2025, and down 18.19% on a QoQ basis from $602411.0 in Q4 2025.
Imunon (IMNN) Operating Leases (2019 - 2026) Analysis & Trends
Imunon (IMNN) has 8 years of Operating Leases data on file, last reported at $492849.0 in Q1 2026.
- Quarterly Operating Leases fell 19.62% year-over-year to $492849.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $492849.0 (down 19.62% YoY) and the FY2025 annual result came in at $602411.0, down 12.3% from the prior year.
- Operating Leases retreated to $492849.0 in Q1 2026, from $602411.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.5 million in Q1 2023 to a low of $53419.0 in Q2 2022.
- A 5-year average of $847161.4 and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases plunged 88.76% — and 2023, when it surged 2447.63%.
- Tracing IMNN's Operating Leases over 5 years: stood at $230749.0 in 2022, then surged by 393.74% to $1.1 million in 2023, then sank by 39.71% to $686935.0 in 2024, then decreased by 12.3% to $602411.0 in 2025, then fell by 18.19% to $492849.0 in 2026.
- The last three Operating Leases figures came in at $492849.0 (Q1 2026), $602411.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 492,849.00 |
| Dec 31, 2025 | 602,411.00 |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 613,171.00 |
| Dec 31, 2024 | 686,935.00 |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 230,749.00 |
| Sep 30, 2022 | 373,525.00 |
| Jun 30, 2022 | 53,419.00 |
| Mar 31, 2022 | 131,819.00 |
| Dec 31, 2021 | 230,749.00 |
| Sep 30, 2021 | 373,526.00 |
| Jun 30, 2021 | 475,051.00 |